Lupin

Lupin launches Mirabegron Extended-Release Tablets in the US

Read more

Making sustainability sustainable

Read more

Lupin launches Doxorubicin Hydrochloride Liposome Injection in the United States

Read more

Lupin receives U.S. FDA approval for Brimonidine Tartrate Ophthalmic Solution

Read more

Lupin gains Health Canada approval for biosimilar Pegfilgrastim

Read more

Balancing cost and value with TCO

Read more

Lupin completes Phase 3 Trials for Lucentis Biosimilar

Read more

Lupin gets USFDA nod for Prednisolone Acetate Ophthalmic Suspension USP

Read more

Lupin secures tentative U.S. FDA approval for generic HIV treatment under PEPFAR

Read more

ForDoz receives USFDA approval for Doxorubicin Hydrochloride Liposome injection

Read more